Coimbra, Portugal

Maria Isabel Lopes Soares

This inventor holds 1 USPTO granted patent. Top assignees: Universidade De Coimbra, University of Porto. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Isabel Lopes Soares. Retrieved from https://idiyas.com/inventor/maria-isabel-lopes-soares

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Maria Isabel Lopes Soares: Innovating in Cancer Treatment**

Introduction

Maria Isabel Lopes Soares is an accomplished inventor based in Coimbra, Portugal, recognized for her significant contributions to the field of cancer research. With a focus on the development of novel therapeutic agents, her research has paved the way for innovative solutions in treating conditions influenced by p53 protein variants.

Latest Patents

Maria Lopes Soares holds a noteworthy patent for her invention titled "(3S)- and (3R)-6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles as P53 activators." This patent encompasses a new chemical family of p53-activating agents, demonstrating higher selectivity towards the p53 pathway in comparison to existing reactivators currently in clinical trials. The compounds showcased in her patent not only exhibit enhanced potency for certain cancer types but are also non-genotoxic and lack undesirable toxic side effects, marking a significant advancement in cancer therapeutics.

Career Highlights

Throughout her career, Maria has worked with prestigious institutions such as the University of Coimbra and the University of Porto. Her tenure at these universities has allowed her to engage in pioneering research, driving forward the understanding and treatment of cancers associated with p53 mutations.

Collaborations

In her innovative journey, Maria collaborated with esteemed colleagues including Lucilia Helena Ataide Saraiva and Joana Oliveira Gama Soares. These partnerships have been pivotal in advancing her research and fostering a collaborative environment conducive to groundbreaking discoveries in cancer therapies.

Conclusion

Maria Isabel Lopes Soares exemplifies the spirit of innovation and dedication in the realm of medical research. Her patent represents a significant step forward in developing targeted cancer treatments, potentially transforming the landscape of oncology. With her ongoing contributions to science, Maria continues to inspire future generations of inventors and researchers in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…